ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,932, issued on Oct. 6, was assigned to GIVAUDAN SA (Vernier, Switzerland).
"Compositions comprising curcuminoids for use in the treatment of muscle soreness" was invented by Julie Laval (Avignon, France), Pascale Elizabeth Renee Fanca-Berthon (Le Thor, France) and Sandra Naranjo Modad (Avignon, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of an improved curcuminoids composition for improving and/or maintaining functional performance and/or relieving, treating, decreasing and/or preventing muscle soreness in a subject during and/or after exercise."
The patent was filed on June 15, 2022, under Applicat...